MAp19 is an alternative splicing product of the MASP-2 gene comprising the N-terminal CUB1-epidermal growth factor (EGF) segment of MASP-2, plus four additional residues at its C-terminal end. Like fulllength MASP-2, it forms Ca 2؉ -dependent complexes with mannan-binding lectin (MBL) and L-ficolin. The x-ray structure of human MAp19 was solved to a resolution of 2.5 Å. It shows a head to tail homodimer held together by interactions between the CUB1 module of one monomer and the EGF module of its counterpart. A Ca 2؉ ion bound to each EGF module stabilizes the dimer interfaces. A second Ca 2؉ ion is bound to the distal end of each CUB1 module, through six ligands contributed by Glu 52 , Asp 60 , Asp 105 , Ser 107 , Asn 108 , and a water molecule. Compared with its counterpart in human C1s, the Nterminal end of the MAp19 CUB1 module contains a 7-residue extension that forms additional inter-monomer contacts. To identify the residues involved in the interaction of MAp19 with MBL and L-ficolin, point mutants were generated and their binding ability was determined using surface plasmon resonance spectroscopy. Six mutations at Tyr 59 , Asp 60 , Glu 83 , Asp 105 , Tyr 106 , and Glu 109 either strongly decreased or abolished interaction with both MBL and L-ficolin. These mutations map a common binding site for these proteins located at the distal end of each CUB1 module and stabilized by the Ca 2؉ ion.